Our group is focused on the development of high throughput microfabricated platforms for the study of liver development, regeneration, and metabolism.

We are interested in Metabolic Programing: understanding how liver cells process information and make metabolic decisions. Our goal is to control patient’s metabolism using this approach. We look toward the development of the next generation of drugs for the treatment of metabolic diseases such as diabetes, obesity, and atherosclerosis.

Located at the Edmond J. Safra campus of the Hebrew University of Jerusalem the MicroLiver Technologies Laboratory is affiliated with the Center for Bioengineering in the Service of Humanity and the Center for Nanotechnology. Our state-of-the-art laboratory is currently being built at the Silberman Institute of Life Sciences. 

Yaakov Nahmias, Ph.D.
Head of Bioengineering Program
Director, Center for Bioengineering
The Hebrew University of Jerusalem